Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases

NCT02913417 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Uveal Melanoma
Hepatic Metastases

Interventions

DEVICE: SIR-Spheres® Yttrium 90
DRUG: ipilimumab
DRUG: nivolumab

Sponsor

David Minor, MD

Collaborators

[object Object]
[object Object]
[object Object]